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ABSTRACT 
Aim. – As periodontitis may contribute to the pathogenesis of diabetes, the effects of 
periodontitis on diabetes incidence and HbA1c change was quantified in a prospective cohort.  
Methods. – Data from an 11-year follow-up of the Study of Health in Pomerania were analyzed 
to evaluate the effects of periodontitis on incident diabetes and long-term HbA1c changes in 
2047 subjects aged 20–81 years. Diabetes was based on self-reported physician diagnoses, 
antidiabetic medication use, or HbA1c ≥ 6.5% or non-fasting blood glucose levels ≥ 11.1 
mmol/L. To assess periodontal status, periodontal pockets were probed, and their depth and 
clinical attachment levels measured. For both measures, means and percentages of sites ≥ 3 mm 
were calculated. In addition, all probing depths ≥ 4 mm were summed (cumulative probing 
depth). Modified Poisson and multivariable linear models were applied, adjusted for age, gender, 
highest level of general education, marital status, waist circumference, physical activity, smoking 
status and follow-up time.  
Results. – Over a mean follow-up period of 11.1 years, 207 subjects developed diabetes. 
Baseline mean clinical attachment levels (CALs) and probing depths (PPDs) were not 
significantly associated with either diabetes incidence [mean CALs, fourth quartile, incidence 
rate ratio = 0.819, 95% confidence interval (CI): 0.489–1.370; P = 0.446] or long-term changes 
in HbA1c (mean CALs, fourth quartile, β = -0.086, 95% CI: -0.187, -0.016; P = 0.098). 
Sensitivity analyses using alternative exposure definitions confirmed these results.  
Conclusion. – Contrary to the currently available literature, no convincing evidence was found 
of any potential association between periodontitis and diabetes incidence or  HbA1c change. 
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INTRODUCTION 
Diabetes mellitus represents a major global health burden. Approximately 415 million people 
worldwide live with diabetes, and this number is expected to increase to 642 million by 2040 [1]. 
Over the next few decades, the prevalence of diabetes is likely to increase in the developed and 
especially the developing countries [2]. For this reason, examining other clinical conditions that 
may predispose to diabetes could have important public-health implications for early diabetes 
care and management.  
Periodontitis is characterized by chronic infection and inflammation of tooth-supporting tissues 
[3]. Periodontal infection may cause systemic inflammation [4] via low-grade, continuous 
bacteraemia or by spillover of proinflammatory cytokines locally produced in the gingiva into 
the bloodstream [5, 6]. In turn, advanced glycation end-products (AGEs) are produced [7], which 
contribute to the onset of diabetes via increased dysregulation of metabolic control [8]. 
In recent years, the bidirectional association between diabetes and chronic periodontitis has 
received considerable attention [9, 10]. However, longitudinal epidemiological data describing 
the effects of periodontitis on the development of diabetes in the general population are scarce 
and have contributed to the current evidence only to a limited degree [11–14]. In the adult US 
population (aged 25–74; n = 9296) examined in the first National Health and Nutrition 
Examination Survey (NHANES) performed in the early 1970s, individuals with higher 
periodontal index categories exhibited greater odds of developing future diabetes [13]. On 
analyzing data from 2973 diabetes-free subjects in the Study of Health in Pomerania (SHIP) 
[15], participants in the highest periodontal disease category [as defined by quartiles (Q) of the 
percentage of sites with clinical attachment levels (CALs) ≥ 5 mm] had a 0.08% higher 5-year 
haemoglobin A1c (HbA1c) change compared with participants in the lowest periodontal disease 
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category. In an Asian retrospective cohort study (n = 22,299), those with periodontitis, as 
indicated by a need for surgery, exhibited a 1.19-fold higher incidence of diabetes than those 
without periodontitis matched from the general population [11]. Another study of 2469 male 
Japanese workers [12] revealed an increased relative risk [risk ratio (RR): 1.73] for incident type 
2 diabetes (T2D) in those reporting tooth loss. In contrast, another study reported a non-
significant association between moderate or severe periodontitis (using scores 3–4 of the 
Community Periodontal Index) and incident diabetes in a large (n = 5848) prospective 7-year 
follow-up study of Japanese adults [14]. While most of these studies were large-scale, they had 
serious limitations in terms of study design, exposure/outcome assessment and/or insufficient 
confounder adjustment, thereby limiting their contribution to the current evidence.  
At present, there is no consensus on the case definition of chronic periodontitis [16, 17]. Thus, 
exposure/outcome effects were estimated using definitions favourable from an epidemiological 
and statistical point of view. Periodontal disease status is commonly assessed by current (pocket 
probing depth, PPD) and cumulative (CAL) disease measures. Using both measures, our present 
study evaluated the different definitions quantifying disease severity (mean) and extent 
(percentage of diseased sites) [18, 19]. In addition, the cumulative PPD, which quantifies current 
periodontal inflammation and is sensitive to reductions in inflammatory exposure, was also 
determined [20]. Exposure definitions were analyzed continuously, thereby reducing the chances 
of misclassification, and as Q1–Q4. By using various exposure definitions and parameters, the 
constancy of the potential exposure/outcome effects was thoroughly evaluated, thus 
strengthening the validity of our conclusions. 
In light of the above facts, the effects of various baseline periodontitis definitions on incident 
diabetes in 2047 diabetes-free individuals were also examined using prospective data from the 
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population-based SHIP-0 and SHIP-2. In addition, the effects of periodontitis definitions on 
long-term changes in HbA1c levels were also assessed.  
 
METHODS 
Study population  
The SHIP is an ongoing longitudinal population-based health survey in West Pomerania [21]. A 
two-stage cluster sampling method was adopted from the World Health Organization (WHO) 
Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) Project based in 
Augsburg, Germany [22]. Caucasian subjects of both genders with German citizenship and main 
residency in the study area were randomly sampled within 12 5-year age-based strata, each 
including 292 subjects. The remaining net sample (excluding the emigrated and deceased) 
comprised 6265 eligible subjects. In the end, 4308 subjects participated in the baseline 
examinations between 1997 and 2001 (SHIP-0). Of these, 3300 subjects participated in the 5-
year SHIP-1 follow-up examinations during 2002–2006. Of the 3708 eligible individuals who 
participated in SHIP-0 and were also invited to participate in the 11-year follow-up, 2333 were 
ultimately examined between 2008 and 2012 (SHIP-2; 62.9% follow-up response) [23].  
The study protocol was approved a priori by the Ethics Committee of the University of 
Greifswald, and written informed consent was obtained from each participant. This study was 
performed in accordance with ‘Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE)’ guidelines for human research studies [24]. 
Detailed information on the non-responses, exclusion criteria, and number and type of missing 
data is presented in Fig. S1 (see supplementary material associated with this article online). Of 
the 2333 subjects who completed the follow-up, 145 participants with prevalent diabetes at 
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baseline were excluded. Information on diabetes status and HbA1c measurements were not 
recorded for a further 124 participants, and data on mean PPD and edentulism at baseline were 
not available for 18 individuals. In addition, 12 subjects were missing covariate information, 
leaving 2034 participants for the final analyses. For analyses of HbA1c changes from baseline, 
the relevant sample comprised 1932 subjects after exclusion of 102 patients taking antidiabetic 
medication.  
 
Periodontitis assessment 
Licensed calibrated dentists (eight in SHIP-0, six in SHIP-2) performed the oral examinations. 
The periodontal recording protocols in SHIP-0 and SHIP-2 were identical. Periodontal 
measurements were assessed at four sites (distobuccal, mesiobuccal, midbuccal, 
midlingual/midpalatinal) per tooth according to the half-mouth method, alternating on the left or 
right side and excluding third molars. A periodontal probe (PCP11, Hu-Friedy Mfg. Co., LLC, 
Chicago, IL, USA) was used to assess PPD and CAL. PPD was measured as the distance 
between the free gingival margin and pocket base, while CAL was the distance between the 
cementoenamel junction (CEJ) and pocket base. If the CEJ was visible, then CAL and PPD were 
measured directly; otherwise, the distance between the gingival margin and CEJ was subtracted 
from the PPD to calculate the CAL. Where the CEJ was indistinct (due to, for example, wedge-
shaped defects, fillings, crown margins), CAL was not recorded. Measurements were 
mathematically rounded to the nearest mm. The number of teeth present was counted, excluding 
third molars.  
Calibration exercises were performed during the course of both studies. Dentists were trained a 
priori by the same periodontist (T.K.). For CAL, interclass correlations were 0.84 in SHIP-0 and 
Page 9 of 36
Ac
ce
pte
d M
an
us
cri
pt
9 
 
0.74 in SHIP-2, whereas intraclass correlations per examiner were 0.82–0.91 in SHIP-0 and 
0.76–0.88 in SHIP-2 [25, 26]. 
To assess periodontitis status, PPD was defined as the primary measure. The mean PPD [19], 
percentage of sites with PPD ≥ 3 mm [18, 19] and cumulative PPD [sum of the deepest PPDs (≥ 
4 mm) per tooth] [20] were calculated on the individual level and categorized as either Q1–Q4 or 
analyzed continuously. CAL was defined as the secondary exposure measure. The mean CAL 
and percentage of sites with CAL ≥ 3 mm [18, 19] were calculated on the subject level and 
categorized as either Q1–Q4 or analyzed continuously. If PPD and CAL definitions were 
analyzed as Q1–Q4, then edentulous subjects were considered an additional category. If PPD and 
CAL definitions were analyzed continuously, then edentulous subjects were excluded. Self-
reported gum treatment between SHIP-0 (baseline) and SHIP-2 was assessed. 
 
Diabetes definition 
At each examination (SHIP-0, SHIP-1, SHIP-2), known diabetes was defined as previously 
diagnosed cases according to self-report d physician diagnoses or treatment with antidiabetic 
medication [Anatomical Therapeutic Chemical (ATC) classification system codes A10A and 
A10B]. At baseline, diabetes was defined as known diabetes in SHIP-0, or as HbA1c levels ≥ 
6.5% [27] or non-fasting blood glucose levels ≥ 11.1 mmol/L (both measured in SHIP-0) [28]. 
For SHIP-2, diabetes was defined as known diabetes in SHIP-2 or HbA1c levels ≥ 6.5% or non-
fasting blood glucose levels ≥ 11.1 mmol/L (both measured in SHIP-2). Incident diabetes was 
the primary outcome, defined as new diabetes cases identified during the entire follow-up period, 
whereas prevalent cases were excluded from the analyses. HbA1c change was considered a 
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secondary outcome (SHIP-2 HbA1c – baseline HbA1c) and, in these HbA1c analyses, subjects 
taking antidiabetic medications during either SHIP-1 or SHIP-2 were excluded. 
 
Laboratory measurements 
Samples for measuring non-fasting blood glucose were taken from the cubital vein with subjects 
in a supine position. HbA1c was measured by high-performance liquid chromatography (Diamat 
Analyzer System, Bio-Rad Laboratories, Hercules, CA, USA), and non-fasting glucose 
concentrations by a Hitachi 717 analyzer (Roche Diagnostics, Mannheim, Germany). High-
density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were 
measured with the Hitachi 704 analyzer (Roche Diagnostics), and high-sensitivity C-reactive 
protein (hs-CRP) was determined immunologically on a Behring Nephelometer II analyzer 
(Dade Behring, Eschborn, Germany).  
 
Covariate assessments 
Sociodemographic and behavioural risk factors were assessed by computer-assisted interviews. 
Socioeconomic status was assessed as the highest level of general (secondary) education 
(categorized as < 10, 10 or > 10 years), with marital status categorized as single and living alone, 
living together, divorced or still married but living alone, or widowed and living alone. To assess 
cigarette-smoking behaviours, information on smoking status (never, former, current) was 
combined with number of pack-years (cigarettes/day for X years of smoking/20). Participants 
were considered physically active if they did ≥ 1 h of physical exercise per week during summer 
or winter. Self-reported dental visits in the past 12 months were categorized as no or yes. Waist 
circumference was measured according to WHO standards, using a measuring tape horizontally 
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midway between the lowermost rib margin and iliac crest (to the nearest 0.1 cm). Lipid-lowering 
medication was defined as ATC codes C10AA and/or C10AB, and antihypertensive medication 
was defined as ATC codes C02A, C03C, C03E, C08DA, C09BA, C07A, C08C, C09AA and/or 
C09CA.  
After a resting period of at least 5 min, systolic (SBP) and diastolic blood pressure (DBP) was 
measured three times on the right arm of seated subjects, using an oscillometric digital blood 
pressure monitor (HEM-705CP, Omron Corporation, Tokyo, Japan). The time interval between 
the three readings was 3 min. The mean of only the second and third measurements was 
calculated, and hypertension was defined as self-reported use of antihypertensive medication, or 
SBP ≥ 140 mmHg or DBP ≥ 90 mmHg.  
 
Statistical analyses 
Directed acyclic graphs (DAGs) were constructed to minimize bias in the selected confounders. 
DAGs are used to explore the causal structure thought to underlie the exposure/outcome 
association of interest [29]. Moreover, they represent a new graphic analytical tool for 
determining adjustment sets [30]. DAGitty software [31] was used for DAG creation and 
determination of minimal sufficient adjustment sets. The final DAG is presented in Fig. S2 (see 
supplementary material associated with this article online). Accordingly, the minimal sufficient 
adjustment set included age, gender, social determinants (assessed by the highest level of general 
education and marital status), smoking status, central adiposity (assessed by waist 
circumference), physical activity and general health behaviour (assessed by self-reported dental 
visits in the past 12 months). To reduce the potential of confounding when estimating the 
exposure/outcome association of interest, factors identified for the minimal sufficient adjustment 
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sets were included as independent variables in regression models (referred to as adjustments). To 
assess the magnitude of confounding by single factors, crude, age- and gender-adjusted, and fully 
adjusted models were also presented. 
Means ± standard deviations (SDs), medians (Q25%–Q75%) or numbers (%) were reported as 
appropriate. Chi-square and Mann–Whitney U tests were used to assess distributional differences 
between unpaired groups. Paired t, McNemar and Wilcoxon signed-rank tests were applied to 
test for distributional differences between paired groups.   
Modified Poisson regression models with robust standard errors were used to estimate risk of 
diabetes in association with periodontal parameters. Incidence rate ratios (IRRs) with 95% 
confidence intervals (CIs) were reported. In addition, multivariable linear regression models 
assessed the effects of baseline periodontitis on long-term HbA1c changes, along with β 
coefficients and 95% CIs. Models were adjusted for age, gender, highest level of general 
education, marital status, waist circumference, physical activity, smoking status and dental visits 
in the last 12 months. Logarithmic follow-up time was considered an offset variable. To retrieve 
P values for linear trends, categorical variables were treated in regression models as if they were 
continuous. To account for selection bias introduced by complete case analyses [32], all analyses 
were weighted using inverse probability weighting (IPW). Logistic models for generating IPWs 
included age, gender, highest level of general education, marital status, smoking status, physical 
activity, waist circumference, hypertension and number of missing teeth.  
All analyses were conducted with Stata/SE 14.1 software (StataCorp, College Station, TX, USA) 
[33]. Two-sided P values < 0.05 were considered statistically significant. 
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RESULTS 
Analyses for incident diabetes 
During a mean follow-up period of 11.1 years, 206 incident diabetes cases were identified (Table 
I). On average, these cases were 9 years older, and exhibited a poorer periodontal status (Table I) 
and a deteriorated metabolic status (Table S1; see supplementary material associated with this 
article online) compared with non-incident subjects. 
In crude models, incidence rates increased significantly across all categories of periodontal 
definitions (Ptrend < 0.001, Table II). For CAL-based definitions, associations diminished after 
inclusion of age and gender, indicating minor confounding by the remaining factors. For PPD-
based definitions, associations diminished after inclusion of age, gender and central adiposity. 
Thus, in the fully adjusted models, no consistently statistically significant effects were observed 
for any of the exposure definitions. Only one significant finding was found when edentulous 
subjects were compared with those with the lowest mean PPD (IRR: 1.973, 95% CI: 1.075–
3.620). Non-significant results were found for quartiles of mean PPD (IRR: 1.271, 95% CI: 
0.782–2.065, Q4 vs Q1) and for quartiles of mean CAL (IRR: 0.819, 95% CI: 0.489–1.370). 
Moreover, there was no apparent overall trend to indicate increasing IRRs across exposure 
categories (Ptrend > 0.05). Whether using continuous definitions of exposure by mean PPD and 
mean CAL (Table II) or alternative periodontitis definitions, such as the cumulative PPD, 
percentage of sites with PPD ≥ 3 mm or percentage of sites with CAL ≥ 3 mm (Table S2; see 
supplementary material associated with this article online), the results were consistent. 
 
Analyses for HbA1c changes 
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Although crude changes in HbA1c levels differed across quartiles of periodontal definitions, 
with the highest levels found for edentulate subjects, periodontal definitions were not associated 
with HbA1c changes in fully adjusted analyses (Table III). Exchanging quartile definitions for 
continuous definitions of mean PPD or mean CAL, or for alternative periodontitis measures such 
as cumulative PPD, percentage of sites with PPD ≥ 3 mm or percentage of sites with CAL ≥ 3 
mm (Table S3; see supplementary material associated with this article online) led to consistent 
results.  
 
DISCUSSION 
The present longitudinal study found no evidence of an association between periodontitis and 
incidence of diabetes after full adjustment for confounders. Moreover, our findings did not 
support the hypothesis that baseline periodontitis may affect HbA1c levels over an average 
period of 11.1 years. Specifically, associations for CAL-based exposure definitions became non-
significant after adjustments for age and gender, indicating minor confounding by the remaining 
factors. For PPD-based exposure definitions, additional adjustment for central adiposity rendered 
the associations non-significant. Thus, our results are not in line with the previous studies that 
reported an association of periodontitis with incident diabetes or HbA1c changes [11–13, 15].  
To explain the lack of association in the present study, the following arguments may be 
considered. The first is survivor bias, meaning that those subjects with periodontitis who were 
more susceptible to diabetes were less likely to complete the follow-up than those with 
periodontitis who were less susceptible to diabetes, and this may have substantially affected the 
composition of the study population by giving rise to a healthier cohort that was not 
representative of the target population. Also, in general, as excluded subjects might differ 
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systematically in their disease profiles from study participants, our effect estimates may have 
been underestimated [34]. To reduce biases, analyses were weighted using IPWs, which largely 
removed selection bias. Second, periodontitis can cause low-grade systemic inflammation, 
thereby affecting progression of insulin resistance [6, 35]. However, no inflammatory 
progression was observed in our incident diabetes and/or prediabetes participants during the 
follow-up (data not shown). In a previous study, a moderate effect of periodontitis on systemic 
inflammation was observed in lean participants, but not in the abdominally obese [36]. The 
reason for such a lack of inflammatory progression might be that participants with incident 
diabetes and/or prediabetes were already on the brink of central adiposity at baseline. Thus, 
progression of inflammation might not have been enough to promote periodontal effects in 
diabetes. 
To date, only limited epidemiological data are available to answer the question of whether severe 
periodontal infections contribute to decreased insulin sensitivity or the development of diabetes 
in diabetes-free individuals. The results of one cross-sectional [13] and three longitudinal studies 
[11, 12, 37] are contrary to those of the present study. The reasons for these discrepancies are 
currently unknown, but might be related to methodological factors. 
In the first population-based longitudinal study of this topic and using data from the first 
NHANES (1971–1976), a non-linear positive association between baseline periodontal disease 
category (defined by quartiles of the percentage of sites with CAL ≥ 5 mm) and incident T2D 
was reported, claiming elevated odds ratios across increasing periodontal disease categories [13]. 
To assess periodontitis, those authors used Russell’s Periodontal Index (RPI), a composite index 
of gingivitis and periodontitis that did not capture the exact severity or extent of probing depth or 
attachment levels. Today, with our better understanding of periodontal disease, the RPI is no 
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longer used because of concerns regarding its validity, underlying assumptions, and poor 
discrimination between moderate and severe periodontitis [38]. Thus, the severity of 
periodontitis might have been overestimated by Demmer et al. [13]. In addition, there were no 
available HbA1c or fasting glucose data to exclude undiagnosed diabetes at baseline, making 
results susceptible to a misclassification bias. In a Taiwanese nationwide retrospective study, 
patients (aged ≥ 40 years) with severe periodontitis (as indicated by subsequent periodontal 
surgery) had an increased risk (HR: 1.19, 95% CI: 1.10–1.29) of future diabetes compared with 
periodontitis patients not undergoing surgery [11]. However, this study is not considered reliable 
because of the uncertainty of the appropriateness of the statistical analyses for the study design 
and inadequate characterization of the two patient groups. In addition, statistical models were not 
adjusted for smoking and central adiposity, factors suggested to be common risk factors for 
periodontitis and diabetes [39, 40]. In particular, central adiposity proved to be a major 
confounder in our analyses. When central adiposity was included in regression models, 
associations became non-significant. Thus, residual confounding might be a serious drawback of 
this Taiwanese study.  
More recently, a 5-year follow-up study of male Japanese workers aged 36–55 years [12] 
observed a similar relationship between the presence of loose teeth and incident diabetes, and 
reported a higher risk after adjusting for confounders (RR: 1.73, 95% CI: 1.14–2.64) in those 
with tooth-loosening. However, periodontitis was only assessed by a self-administered 
questionnaire that included questions about gingival haemorrhage or tooth-loosening at baseline, 
with no clinical assessment. Furthermore, measurements of HbA1c to detect cases of prediabetes 
at baseline were not fully available during the study. As a consequence, diabetes patients were 
probably not definitively identified, which may have introduced a misclassification bias and, 
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thus, a shift of risk estimates to a null effect. In contrast to previous studies but in accordance 
with our present one, a large prospective study [14] comprising 5848 diabetes-free Japanese 
subjects aged 30–59 years found a non-significant association (HR: 1.28, 95% CI: 0.89–1.86) 
between severe periodontitis and diabetes incidence. Thus far, the current literature has provided 
no concrete evidence of a causal association between periodontitis and diabetes incidence, with 
the methodological quality of the available studies being a major issue. Finally, direct 
comparisons between studies may not be deemed appropriate because of other, variable factors, 
such as the characteristics of the study population and use of different diagnostic criteria for 
exposure/outcome.  
The present study was well designed, and clearly delineates the temporality of exposure and 
outcome. The SHIP is a large-scale population-based study covering a wide age range (20–81 
years). Also, exposure was comprehensively assessed using clinical measurements to define 
severity (mean PPD, mean CAL) and extent of periodontitis (percentage of sites with PPD ≥ 3 
mm, percentage of sites with CAL ≥ 3 mm), and also the cumulative inflammatory burden 
(cumulative PPD). Furthermore, edentulism as a long-term consequence of untreated severe 
periodontitis was analyzed. The fact that all of the various exposure definitions led to the same 
results strengthens the finding that periodontitis was not associated with either incident diabetes 
or HbA1c changes in the present study. 
The presence of diabetes was ascertained by physician diagnoses, use of antidiabetic 
medications, and HbA1c and non-fasting plasma glucose measurements to minimize 
misclassification bias. In addition, two outcome definitions were employed. The diabetes 
definition provides easily interpretable IRRs as effects estimates and also includes participants 
taking antidiabetic medications, making it the better outcome definition for our study. For the 
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HbA1c analyses, subjects taking newly prescribed antidiabetic medications were excluded to 
prevent attenuation of HbA1c changes and, in turn, attenuation of effects estimates. Using both 
outcome definitions led to similar findings, thereby strengthening the credibility of our findings. 
Furthermore, the long prospective follow-up and comprehensive adjustment of confounders 
increases the relevance of our study as evidence concerning the periodontitis–diabetes 
relationship. 
However, at least six limitations of the present study merit consideration. First, because the study 
sample solely comprised Caucasians from northeast Germany, our findings cannot be 
generalized to other ethnicities. Second, as full-mouth examinations with six sites per tooth (the 
gold standard) would have been too time-consuming and cost-intensive, the SHIP used a half-
mouth protocol with only four sites, which might have led to underestimation of periodontal 
disease severity [41, 42], with dilution of effects estimates towards null, assuming that 
misclassification occurred non-differentially [43]. Third, although DAGs informed by clinical 
and epidemiological knowledge were used to etermine our adjustment sets, it is not possible to 
entirely exclude the possibility of residual confounding by, for instance, diet, genetic factors or 
other, unknown factors not considered in the DAG. Fourth, HbA1c change was assessed using 
measurements at two time points, thereby reflecting glycaemic variability to only a limited 
extent. However, analyses of HbA1c change considering three time points (SHIP-0/-1/-2) were 
not possible. Fifth, because the periodontal probe used in SHIP-1 was different from those of 
SHIP-0 and SHIP-2 [44], their periodontal measurements are not comparable. Finally, 21% of 
subjects (n = 1985 due to missing information) reported having some form of ‘gum treatment’ 
between baseline and the end of the 11-year follow-up. However, no details of the type and 
duration of such treatment were available. Also, as patients may not have a clear understanding 
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of what the standard periodontal treatment is [45], such self-reported ‘gum treatment’ should 
perhaps be interpreted with caution. Thus, the percentage of subjects receiving regular 
periodontal therapy during follow-up can be assumed to be much lower, with negligible effects 
on HbA1c change and its association with periodontitis. 
 
CONCLUSION 
Periodontitis was not associated with incident diabetes after making DAG-guided comprehensive 
adjustments to the prospective 11-year follow-up data from the SHIP. Thus, our findings do not 
support the hypothesis that baseline or periodontitis progression may have an effect on HbA1c 
changes. Large prospective cohort studies of diverse populations, which will minimize bias at 
both design and analytical stages, are necessary to further scrutinize the evidence for this 
relationship.  
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Supplemetary figure legends 
 
Fig. S1. Flow chart of the study analysis set showing reasons for non-response in the second 
Study of Health in Pomerania (SHIP-2), as well as the exclusion criteria, and number and type of 
missing data.  
Fig. S2. The main directed acyclic graph (DAG) created to evaluate the association between 
periodontitis and diabetes. 
 
 
 
Table I. Baseline characteristics of Study of Health in Pomerania (SHIP-0) participants by incident diabetes over the 
11-year follow-up 
 Diabetes 
prevalence 
(n = 145) 
Analyses of incident diabetes Analyses of 
HbA1c change  
  Non-incident  
(n = 1828) 
Incident 
(n = 206) 
Total sample  
(n = 1932) 
Age, years 56.8 ± 10.3 45.0 ± 13.4 53.7 ± 11.8#  45.4 ± 13.5 
Gender:     
   Female 57 (39.3) 989 (54.1) 96 (46.6) 1043 (54.0) 
   Male 88 (60.7) 839 (45.9) 110 (53.4)# 889 (46.0) 
Highest level of general education:     
   < 10 years 82 (56.6) 439 (24.0) 86 (41.8) 482 (24.9) 
   10 years 41 (28.3) 1005 (55.0) 92 (44.7) 1049 (54.3) 
   > 10 years 22 (15.2) 384 (21.0) 28 (13.5)# 401 (20.8) 
Marital status:     
   Single, living alone 6 (4.1) 198 (10.8) 13 (6.3) 203 (10.5) 
   Living together 121 (83.5) 1476 (80.7) 160 (77.7) 1553 (80.4) 
   Divorced or still married, but living alone 8 (5.5) 95 (5.2) 22 (10.7) 109 (5.6) 
   Widowed, living alone 10 (6.9) 59 (3.2) 11 (5.3)# 67 (3.5) 
Smoking status:      
   Never smoker 49 (33.8) 736 (40.3) 76 (36.9) 774 (40.1) 
   Former smoker, < 20 pack years 49 (33.8) 509 (27.8) 57 (27.7) 540 (28.0) 
   Former smoker, ≥ 20 pack years 19 (13.1) 93 (5.1) 21 (10.2) 101 (5.2) 
   Current smoker, < 20 pack years 10 (6.9) 359 (19.6) 23 (11.2) 372 (19.2) 
   Current smoker, ≥ 20 pack years 18 (12.4) 131 (7.2) 29 (14.1)# 147 (7.5) 
Physical activity, yes 39 (26.9) 897 (49.1) 80 (38.8)# 937 (48.5) 
Waist circumference, cm 100.0 ± 12.9 85.7 ± 12.7 98.1 ± 12.0# 86.2 ± 12.8 
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HbA1c, % 7.2 ± 1.5 5.1 ± 0.5 5.7 ± 0.5# 5.2 ± 0.5 
Edentulous, yes 21 (14.5) 65 (3.5) 26 (12.6)# 75 (3.9) 
Number of missing teeth 10 (5–22) 4 (2–9) 8 (3–19)# 5 (2–10) 
Mean PPD, mm* 2.77 ± 0.82 2.40 ± 0.65 2.63 ± 0.75# 2.41 ± 0.64 
Mean CAL, mm† 3.39 ± 1.71 2.27 ± 1.60 2.94 ± 1.62# 2.29 ± 1.60 
Data are means ± SD or medians (Q25%–Q75% for number of missing teeth) or numbers (%); * n = 123 subjects 
with prevalent diabetes; † n = 114/1887/1805 for subjects with prevalent diabetes/in incident diabetes analysis set/in 
HbA1c change analysis set; # P < 0.05 for incident vs non-incident subjects, calculated by Mann–Whitney U 
(continuous variables) or chi-square (categorical variables) tests; 
HbA1c: haemoglobin A1c; PPD: pocket probing depth; CAL: clinical attachment level 
 
 
 
Table II. Results of modified Poisson models regressing incident diabetes on baseline periodontal status 
 Incidence rate 
(per 1000 
person-years) 
Crude IRR 
(95% CI) 
Age-/gender-
adjusted 
IRR (95% CI) 
Fully 
adjusted 
IRR (95% 
CI) 
P 
Mean pocket probing depth, mm 
Analyzed as quartiles 
(Q; n = 2034) 
     
Q1 (0.95–1.97)  4.3 1.00 (reference) 1.00 (reference) 1.00 
(reference) 
 
Q2 (1.98–2.30) 8.7 2.185 (1.325–
3.603)* 
1.873 (1.136–
3.087)* 
1.352 (0.819–
2.232) 
0.239 
Q3 (2.31–2.69) 8.8 2.304 (1.397–
3.802)* 
1.733 (1.047–
2.868)* 
1.224 (0.749–
1.999) 
0.420 
Q4 (2.70–7.25) 11.6 2.842 (1.759–
4.593)* 
1.925 (1.173–
3.158)* 
1.271 (0.782–
2.065) 
0.333 
Edentulous 25.8 5.989 (3.489–
10.280)* 
2.858 (1.587–
5.146)* 
1.973 (1.075–
3.620) 
0.028 
  Ptrend < 0.001 Ptrend = 0.003 Ptrend = 0.110  
Analyzed 
continuously (n = 
1943) 
– 1.397 (1.207–
1.618)* 
1.231 (1.030–
1.471)* 
1.061 (0.876–
1.286) 
0.545 
Mean clinical attachment level, mm 
Analyzed as Q (n = 
1978) 
     
Q1 (0–1.15)  4.7 1.00 (reference) 1.00 (reference) 1.00 
(reference) 
 
Q2 (1.16–2.04) 4.6 0.955 (0.545–
1.674) 
0.740 (0.421–
1.302) 
0.610 (0.357–
1.040) 
0.069 
Q3 (2.05–3.14) 9.4 1.940 (1.201–
3.135)* 
1.162 (0.679–
1.989) 
0.915 (0.563–
1.489) 
0.722 
Q4 (3.15–12.25) 13.9 2.853 (1.809–
4.501)* 
1.382 (0.765–
2.495) 
0.819 (0.489–
1.370) 
0.446 
Edentulous 25.8 5.186 (3.068–
8.769)* 
2.029 (1.008–
4.082)* 
1.300 (0.666–
2.539) 
0.442 
  Ptrend < 0.001 Ptrend = 0.011 Ptrend = 0.30  
Analyzed 
continuously (n = 
– 1.173 (1.102–
1.249)* 
1.024 (0.929–
1.127) 
0.929 (0.836–
1.034) 
0.177 
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continuously (n = 
1887) 
1.249)* 1.127) 1.034) 
Fully adjusted models included age, gender, highest level of general education, marital status, waist 
circumference, physical activity, smoking status (5 categories, including pack-years), dental visits in past 
12 months, follow-up time (ln, offset); all models were weighted using inverse probability weighting; 
* P < 0.05; 
IRR: incidence rate ratio; CI: confidence interval 
 
 
Table III. Results of linear regression models evaluating associations between baseline periodontal status 
and 11-year changes in haemoglobin A1c (HbA1c, %) in subjects not taking antidiabetic medications 
 Changes in 
HbA1c, % 
Crude  
β (95% CI) 
Age-/gender-
adjusted 
β (95% CI) 
Fully adjusted 
β (95% CI) 
P 
Mean pocket probing depth, mm 
Analyzed as quartiles 
(Q, n = 1932) 
     
Q1 (0.95–1.97) 0.13 ± 0.58 0.00 (reference) 0.00 (reference) 0.00 (reference)  
Q2 (1.98–2.30) 0.22 ± 0.76 0.082 (-0.006–
0.170) 
0.067 (-0.022–
0.156) 
0.062 (-0.027–
0.151) 
0.172 
Q3 (2.31–2.68) 0.18 ± 0.56 0.060 (-0.020–
0.140) 
0.026 (-0.058–
0.111) 
0.003 (-0.081–
0.087) 
0.939 
Q4 (2.69–7.25) 0.25 ± 0.67 0.123 (0.041–
0.206)* 
0.074 (-0.015–
0.164) 
0.038 (-0.053–
0.129) 
0.414 
Edentulous 0.23 ± 0.54 0.126 (-0.026–
0.278) 
0.042 (-0.119–
0.203) 
0.009 (-0.156–
0.174) 
0.915 
  Ptrend = 0.013 Ptrend = 0.321 Ptrend = 0.848  
Analyzed continuously 
(n = 1857) 
0.19 ± 0.65 0.046 (0.001–
0.091)* 
0.025 (-0.022–
0.072) 
0.003 (-0.045–
0.051) 
0.914 
Mean clinical attachment level, mm 
Analyzed as Q (n = 1880)      
Q1 (0–1.12) 0.18 ± 0.73 0.00 (reference) 0.00 (reference) 0.00 (reference)  
Q2 (1.13–2.01) 0.20 ± 0.56 0.042 (-0.040–
0.124) 
0.009 (-0.074–
0.091) 
-0.010 (-0.091–
0.072) 
0.820 
Q3 (2.02–3.09) 0.17 ± 0.58 0.041 (-0.046–
0.127) 
-0.028 (-0.116–
0.060) 
-0.062 (-0.152–
0.027) 
0.173 
Q4 (3.10–12.25) 0.22 ± 0.69 0.084 (-0.004–
0.173) 
-0.019 (-0.125–
0.086) 
-0.086 (-0.187–
0.016) 
0.098 
Edentulous 0.23 ± 0.54 0.104 (-0.049–
0.257) 
-0.029 (-0.195–
0.137) 
-0.096 (-0.263–
0.072) 
0.262 
  Ptrend = 0.054 Ptrend = 0.584 Ptrend = 0.071  
Analyzed continuously 
(n = 1805) 
0.19 ± 0.64 0.018 (-0.005–
0.041) 
0.001 (-0.029–
0.031) 
-0.013 (-0.042–
0.015) 
0.364 
Changes in HbA1c are means ± SD; models were adjusted for age, gender, highest level of general 
education, marital status, waist circumference, physical activity, smoking status (5 categories, 
including pack-years), dental visits in past 12 months, follow-up time (ln, offset), and weighted 
using inverse probability weighting; 
β: linear regression coefficient; CI: confidence interval 
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Table S1. Additional clinical baseline data used for analyses of incident diabetes and changes in 
haemoglobin A1c (HbA1c) from baseline 
 Analyses of incident diabetes Analyses of HbA1c 
change 
  Incident diabetes    
 n 
(non-
incident/incident) 
No Yes P n Total 
sample 
 
Serum glucose, 
mmol/L 
1808/198 5.21 ± 
0.70 
5.93 ± 
1.13 
0.0001 1908 5.23 ± 0.72 
HDL-C, mmol/L  1808/198 1.51 ± 
0.42 
1.28 ± 
0.36 
0.0001 1908 1.51 ± 0.42 
LDL-C, mmol/L  1808/198 3.51 ± 
1.14 
3.87 ± 
1.28 
0.0001 1908 3.52 ± 1.15 
Lipid medication* 1808/198    1908  
No  1731 
(95.7) 
176 
(88.9) 
  1820 (95.4) 
Yes  77 (4.3) 22 
(11.1) 
< 
0.0001 
 88 (4.6) 
Antihypertensive 
medication# 
1808/198    1908  
No  1526 
(84.4) 
119 
(60.1) 
   1595 (83.6) 
Yes  282 
(15.6) 
79 
(39.9) 
< 
0.0001 
 313 (16.4) 
Hypertension†  1808/198    1908  
No  1053 
(58.2) 
60 
(30.3) 
  1096 (57.4) 
Yes  755 
(41.8) 
138 
(69.7) 
< 
0.0001 
 812 (42.6) 
hs-CRP, mg/L 1646/181 1.92 ± 
2.21 
2.98 ± 
2.76 
0.0001 1739 1.98 ± 2.28 
≤ 2 mg/L 1760/193 1220 
(69.3) 
99 
(51.3) 
 1739 1216 (69.9) 
> 2 mg/L but ≤ 3 mg/L  194 
(11.0) 
16 (8.3)   179 (10.3) 
> 3 mg/L  346 
(19.7) 
78 
(40.4) 
< 
0.0001 
 344 (19.8) 
Data are means ± SD or numbers (%); P values were calculated by Mann–Whitney U (continuous variables) and chi-
square (categorical variables) tests; * ATC codes C10AA, C10AB; # ATC codes C02A, CO3C, C03E, C08DA, C09BA, 
C07A, C08C, C09AA, C09CA; † use of antihypertensive medications, or systolic blood pressure ≥ 140 mmHg or diastolic 
blood pressure ≥ 90 mmHg; 
HDL-C/LDL-C: high-density lipoprotein/low-density lipoprotein cholesterol; hs-CRP: high-sensitivity C-reactive protein 
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Table S2. Results of modified Poisson models regressing incident diabetes on baseline periodontal status 
 Incidence rate 
(per 1000 
person-years) 
Crude 
IRR (95% 
CI) 
Age-/gender-
adjusted 
IRR (95% CI) 
Fully 
adjusted 
IRR (95% 
CI) 
P 
Percentage of sites with PPD ≥ 3 mm 
Analyzed as quartiles (Q, n 
= 2034) 
     
Q1 (0–25.4)  5.5 1.00 
(reference) 
1.00 
(reference) 
1.00 
(reference) 
 
Q2 (25.5–41.7) 9.0 1.658 (1.055–
2.605)* 
1.551 (0.995–
2.418) 
1.423 (0.908–
2.232) 
0.124 
Q3 (41.8–59.5) 6.7 1.215 (0.754–
1.957) 
0.987 (0.611–
1.594) 
0.823 (0.509–
1.329) 
0.425 
Q4 (59.6–100) 12.5 2.325 (1.523–
3.549)* 
1.711 (1.113–
2.631)* 
1.253 (0.808–
1.943) 
0.313 
Edentulous 25.8 4.424 (2.698–
7.255) 
2.228 (1.307– 
3.798)* 
1.783 (1.014–
3.137) 
0.045 
  Ptrend < 0.001 Ptrend = 0.004 Ptrend = 0.139  
Analyzed continuously, per 
10% increase (n = 1943) 
– 1.012 (1.007–
1.018)* 
1.008 (1.001–
1.014)* 
1.009 (0.948–
1.073) 
0.786 
Cumulative PPD 
Analyzed as Q (n = 2034)      
Q1 (0–3)  5.9 1.00 
(reference) 
1.00 
(reference) 
1.00 
(reference) 
 
Q2 (4–8) 7.7 1.143 (0.733–
1.782) 
1.024 (0.657–
1.596) 
0.986 (0.635–
1.531) 
0.951 
Q3 (9–18) 10.2 1.551 (0.999–
2.407) 
1.196 (0.768–
1.862) 
1.086 (0.710–
1.661) 
0.705 
Q4 (19–97) 10.5 1.666 (1.102–
2.519)* 
1.374 (0.910–
2.075) 
1.125 (0.751–
1.684) 
0.568 
Edentulous 25.8 3.693 (2.293–
5.948)* 
1.884 (1.117–
3.177)* 
1.670 (0.983–
2.837) 
0.058 
  Ptrend < 0.001 Ptrend = 0.008 Ptrend = 0.077  
Analyzed continuously per 
10% increase (n = 1943) 
– 1.115 (1.027–
1.211)* 
1.090 (0.997–
1.191) 
1.026 (0.938–
1.121) 
0.579 
Percentage of sites with CAL ≥ 3 mm 
Analyzed as Q (n = 1978)      
Q1 (0–10.8)  3.9 1.00 
(reference) 
1.00 
(reference) 
1.00 
(reference) 
 
Q2 (10.9–35.8) 6.0 1.545 (0.885–
2.699) 
1.132 (0.646–
1.985) 
0.859 (0.499–
1.480) 
0.585 
Q3 (35.9–70.3) 9.4 2.427 (1.453–
4.051)* 
1.403 (0.812–
2.423) 
0.997 (0.591–
1.680) 
0.990 
Q4 (70.4–100) 13.3 3.334 (2.038–
5.455)* 
1.588 (0.870–
2.897) 
0.917 (0.527–
1.596) 
0.758 
Edentulous 25.8 6.349 (3.646–
11.056)* 
2.400 (1.193–
4.831)* 
1.468 (0.726–
2.967) 
0.285 
  Ptrend < 0.001 Ptrend = 0.010 Ptrend = 0.298  
Analyzed continuously, per 
10% increase (n = 1887) 
– 1.134 (1.086– 
1.183) * 
1.050 (0.990–
1.114) 
0.983 (0.932– 
1.037) 
0.532 
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10% increase (n = 1887) 1.183) * 1.114) 1.037) 
Models adjusted for age, gender, highest level of general education, marital status, waist 
circumference, physical activity, smoking status (5 categories, including pack-years), dental visits in 
last 12 months, follow-up time (ln, offset), and weighted using inverse probability weighting; * P < 
0.05;  
IRR: incidence rate ratio; CI: confidence interval; PPD: pocket probing depth; CAL: clinical 
attachment level 
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Table S3. Results of linear regression models evaluating associations between baseline periodontal status 
(additional periodontitis definitions) and 11-year changes in haemoglobin A1c (HbA1c) in subjects not 
taking antidiabetic medications 
 Changes in 
HbA1c, % 
Crude  
β (95% CI) 
Age-/gender-
adjusted 
β (95% CI) 
Fully 
adjusted 
β (95% CI) 
P 
Percentage of sites with PPD ≥ 3 mm, %  
Analyzed as quartiles (Q, n 
= 1932) 
     
Q1 (0–25.4) 0.14 ± 0.55 0.00 
(reference) 
0.00 
(reference) 
0.00 
(reference) 
 
Q2 (25.5–41.7) 0.22 ± 0.80 0.084 (-0.006–
0.173) 
0.076 (-0.013–
0.165) 
0.062 (-0.028–
0.151) 
0.177 
Q3 (41.8–58.7) 0.17 ± 0.54 0.029 (-0.046–
0.103) 
0.0004 (-
0.077–0.077) 
-0.019 (-
0.098–0.061) 
0.644 
Q4 (58.8–100) 0.25 ± 0.68 0.130 (0.049–
0.211) 
0.090 (0.007–
0.174)* 
0.047 (-0.042–
0.136) 
0.297 
Edentulous 0.23 ± 0.54 0.118 (-0.032–
0.269) 
0.039 (-0.116–
0.194) 
0.005 (-0.153–
0.164) 
0.947 
  Ptrend = 0.011 Ptrend = 0.211 Ptrend = 0.734  
Analyzed continuously, per 
10% increase (n = 1857) 
0.19 ± 0.65 0.020 (0.007–
0.033)* 
0.015 (0.001–
0.028)* 
0.008 (-0.007–
0.023) 
0.298 
Cumulative PPD, mm  
Analyzed as Q (n = 1932)      
Q1 (0–3) 0.15 ± 0.55 0.00 
(reference) 
0.00 
(reference) 
0.00 
(reference) 
 
Q2 (4–8) 0.21 ± 0.78 0.081 (-0.006–
0.167) 
0.065 (-0.022–
0.152) 
0.043 (-0.042–
0.128) 
0.322 
Q3 (9–18) 0.19 ± 0.57 0.039 (-0.039–
0.117) 
0.002 (-0.079–
0.083) 
-0.022 (-
0.103–0.059) 
0.597 
Q4 (19–97) 0.23 ± 0.66 0.085 (0.008–
0.162)* 
0.055 (-0.025–
0.134) 
0.026 (-0.053–
0.105) 
0.520 
Edentulous 0.23 ± 0.54 0.105 (-0.044–
0.255) 
0.023 (-0.133–
0.178) 
-0.008 (-
0.164–0.149) 
0.924 
  Ptrend = 0.068 Ptrend = 0.541 Ptrend = 0.993  
Analyzed continuously, per 
10% increase (n = 1857) 
0.19 ± 0.65 0.018 (-0.005–
0.041) 
0.013 (-0.011–
0.036) 
0.007 (-0.016–
0.030) 
0.544 
Percentage of sites with CAL ≥ 3 mm, % 
Analyzed as Q (n = 1880)      
Q1 (0–10.5) 0.17 ± 0.71 0.00 
(reference) 
0.00 
(reference) 
0.00 
(reference) 
 
Q2 (10.6–35.0) 0.19 ± 0.57 0.040 (-0.041–
0.122) 
0.005 (-0.078–
0.088) 
-0.007 (-
0.089–0.074) 
0.858 
Q3 (35.1–69.3) 0.17 ± 0.58 0.039 (-0.046–
0.124) 
-0.025 (-
0.113–0.064) 
-0.053 (-
0.141–0.034) 
0.233 
Q4 (69.4–100) 0.24 ± 0.69 0.105 (0.018–
0.193)* 
0.014 (-0.089–
0.118) 
-0.050 (-
0.150–0.049) 
0.319 
Edentulous 0.23 ± 0.54 0.109 (-0.043–
0.262) 
-0.009 (-
0.174–0.157) 
-0.070 (-
0.236–0.096) 
0.407 
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0.262) 0.174–0.157) 0.236–0.096) 
  Ptrend = 0.021 Ptrend = 0.950 Ptrend = 0.225  
Analyzed continuously, per 
10% increase (n = 1805) 
0.19 ± 0.64 0.011 (0.001–
0.021)* 
0.003 (-0.010–
0.015) 
-0.005 (-
0.017–0.007) 
0.411 
Data are means ± SD unless otherwise indicated; models were adjusted for age, gender, highest 
level of general education, marital status, waist circumference, physical activity, smoking status (5 
categories, including pack-years), dental visits in last 12 months, follow-up time (ln, offset), and 
weighted using inverse probability weighting; * P < 0.05; 
PPD: pocket probing depth; CAL: clinical attachment level 
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Fig. S1. Flow chart of the analysis set, showing reasons for nonresponse in SHIP-2 and exclusion 
criteria and number and type of missing data. 
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Fig. S2. The main directed acyclic graph (DAG) to evaluate the association between 
periodontitis and diabetes mellitus. 
 
 
 
 
 
 
 
 
 
